Nordex: Profit Warning from May 2022 underestimated actual costs
RECAP: Back in May 25, 2022, Nordex issued a profit warning and its stock was down -17.05%. The new estimates where:
FY2022 PROFIT WARNING ESTIMATES FROM MAY 2022 (Source: Nordex's IR website section):
– FY2022 Consolidated sales: EUR 5.2 to 5.7 billion
– FY2022 EBITDA-margin: minus 4 to 0 percent, including all one-off effects
- Capital expenditure: EUR 180 million
- Working capital ratio: below -7%
In March 31st, 2023 investors got to know the actual figures of the company.
FY2022 ACTUALS (Source: Nordex's IR website section):
– FY2022 Consolidated sales: EUR 5.6936 billion
– FY2022 EBITDA-margin: -4.3%
- Capital expenditure: EUR 204.8 million
- Working capital ratio: -10.2%
Capital expenditure and staff costs were up 21.4% and 18.5%, respectively.
The company suffers from delays in project intakes.
Overall, I reckon Consolidated sales were in the upper boundary of the profit warning but costs increased dramatically, probably due to inflation and related supply-chain issues that are still not fully corrected from China today, in 2023.
FY2022 PROFIT WARNING ESTIMATES FROM MAY 2022 (Source: Nordex's IR website section):
– FY2022 Consolidated sales: EUR 5.2 to 5.7 billion
– FY2022 EBITDA-margin: minus 4 to 0 percent, including all one-off effects
- Capital expenditure: EUR 180 million
- Working capital ratio: below -7%
In March 31st, 2023 investors got to know the actual figures of the company.
FY2022 ACTUALS (Source: Nordex's IR website section):
– FY2022 Consolidated sales: EUR 5.6936 billion
– FY2022 EBITDA-margin: -4.3%
- Capital expenditure: EUR 204.8 million
- Working capital ratio: -10.2%
Capital expenditure and staff costs were up 21.4% and 18.5%, respectively.
The company suffers from delays in project intakes.
Overall, I reckon Consolidated sales were in the upper boundary of the profit warning but costs increased dramatically, probably due to inflation and related supply-chain issues that are still not fully corrected from China today, in 2023.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.